International Medical Case Reports Journal (Feb 2021)
Iron Deficiency Anemia Refractory to Conventional Therapy but Responsive to Feralgine® in a Young Woman with Celiac Disease
Abstract
Valentina Talarico,1 Laura Giancotti,2 Roberto Miniero,1 Marco Bertini3 1Department of Pediatric, Pugliese-Ciaccio Hospital, Catanzaro, Italy; 2Unit of Pediatrics, University “Magna Graecia”, Catanzaro, Italy; 3R&D Department, Laboratori Baldacci SpA, Pisa, ItalyCorrespondence: Valentina TalaricoDepartment of Pediatrics, Pugliese-Ciaccio Hospital, Viale Pio X, Catanzaro, 88100, ItalyTel +3402457848Email [email protected]: Iron, which is an important micronutrient in the human body may be deficient in people with celiac disease (CD). Iron deficiency anemia (IDA) may be the presenting feature of celiac disease, also in the absence of diarrhea or weight loss. The treatment of IDA in patient with CD is primarily a gluten-free-diet (GFD), but it is also very important oral iron supplementation until the iron stores have been restored. However, a frequent problem in CD is the poor tolerability and poor efficacy of oral iron preparations. A new product, consisting of the combination of Ferrous Bysglicinate Chelate and Sodium Alginate (Feralgine™), has been demonstrated to be more bioavailable and well tolerated in CD. We present a case report that showed a clear efficacy of this product in a form of IDA refractory to conventional therapy in a woman with CD and we demonstrated a clear increase of serum iron after administration of this new type of ferrous.Keywords: celiac disease, iron deficiency anemia, ferrous bisglycinate chelate, sodium alginate, OIAT
